Indraprastha Medical PAT up 27 per cent, recommends dividend
Indraprastha Medical Corporation declared its financial results for the quarter ended March 2019.
On the standalone financial front, total income from operations stood at Rs. 200.42 crore in Q4FY19 as against Rs. 189.05 crore in Q4FY18, posting a YoY growth of 6.01 per cent. EBITDA remained mostly flat at Rs. 19.48 crore in Q4FY19 as against Rs. 19.80 crore in Q4FY18, posting a minor fall of 1.62 per cent. PAT climbed to Rs. 7.14 crore in Q4FY19 from Rs. 5.58 crore in Q4FY18, marking an increase of 27.96 per cent. EPS increased to Rs. 0.78 in Q4FY19 from Rs. 0.61 in Q4FY18, thereby rising 27.87 per cent.
Furthermore, the Board of Directors recommended a dividend of 16 per cent, amounting to Rs. 1.60 per share, for the financial year 2018-2019.
On Thursday, the shares of Indraprastha Medical Corp. opened at Rs. 38.55 and hit a high and low of Rs. 38.60 and Rs. 37.95, respectively. The stock closed at Rs. 38.25, up 0.53 per cent.